Leann Mayer
Gerontology · Bluffton, INNPI 1114678869
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.
Across 33 payments — averaging $82.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$483
- Teva Pharmaceuticals USA, Inc.$365
- Inspire Medical Systems, Inc.$241
- Otsuka America Pharmaceutical, Inc.$236
- AbbVie$143
- Bioventus LLC$132
- plus $1K from 12 others
What the payments were for
- Food & beverage$2,731100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 5 | $483 |
| Teva Pharmaceuticals USA, Inc. | 3 | $365 |
| Inspire Medical Systems, Inc. | 2 | $241 |
| Otsuka America Pharmaceutical, Inc. | 3 | $236 |
| AbbVie | 2 | $143 |
| Bioventus LLC | 1 | $132 |
| Eisai Inc. | 1 | $124 |
| Sanofi-aventis U.S. LLC | 1 | $121 |
| Gilead | 1 | $109 |
| Bayer | 1 | $107 |
| Neurocrine Biosciences, Inc. | 3 | $105 |
| Corcept Therapeutics | 1 | $102 |
| Boehringer Ingelheim | 1 | $98 |
| Lundbeck LLC | 1 | $97 |
| Lilly USA, LLC | 4 | $84 |
| Tactile Systems Technology Inc | 1 | $69 |
| Mallinckrodt Hospital Products Inc. | 1 | $59 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,731 in reported general payments places this provider in the 85th percentile of 230 gerontology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 244 | $97,627 |
| GemtesaVibegron | 248 | $74,682 |
| TrulicityDulaglutide | 99 | $59,714 |
| JardianceEmpagliflozin | 74 | $39,421 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $19,537 |
| MyrbetriqMirabegron | 24 | $12,997 |
| XareltoRivaroxaban | 33 | $12,494 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 52 | $10,679 |
| Potassium Chloride | 245 | $9,254 |
| NamzaricMemantine Hcl/Donepezil Hcl | 29 | $9,107 |
| TradjentaLinagliptin | 11 | $8,823 |
| FarxigaDapagliflozin Propanediol | 14 | $8,204 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 75 | $7,885 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $7,820 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $7,801 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $84 | $59,71499 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $98 | $56,044100 claims |
| AbbVieNamzaric | $143 | $9,10729 claims |
| AstraZenecaFarxiga | $483 | $8,20414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 230 gerontology providers in Indiana.
Other gerontology in Bluffton
- Angela PattiMunster$44K
- Jessica KiszkaMunster$42K
- Sandra GarofaloIndianapolis$24K
- Megan MonnierBloomington$23K
- Diane BrackinFishers$13K
- Karie BeasleyEvansville$13K
- Mary ParkerFort Wayne$13K
- Morgan SlawsonMunster$9K
- Marena ArnoldFort Wayne$8K
- Beau SemlerDanville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.